126 related articles for article (PubMed ID: 5171223)
1. New cancerostatics developed in Czechoslovakia. Introductory lecture.
Semonský M
Neoplasma; 1971; 18(5):431-4. PubMed ID: 5171223
[No Abstract] [Full Text] [Related]
2. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM).
Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S
Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515
[No Abstract] [Full Text] [Related]
3. Contribution to elucidation of biochemical action mechanism of Cytembena.
Slavíková V; Semonský M; Slavík K; Zikán V; Bloch A; Veselá H
Neoplasma; 1971; 18(5):455-7. PubMed ID: 5119518
[No Abstract] [Full Text] [Related]
4. Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils.
Fabrissin S; de Nardo M; Nisi C; Morasca L; Dolfini E; Franchi G
J Med Chem; 1976 May; 19(5):639-42. PubMed ID: 1271405
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms of action of antitumor compounds.
Belousova AK
Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
[No Abstract] [Full Text] [Related]
6. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
Veselá H; Jelínek V; Pujman V; Zlatkovská Z
Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
[No Abstract] [Full Text] [Related]
7. Effect of cytostatics on the uterotrophic action of estrogens.
Jelínek V; Rezábek K
Neoplasma; 1969; 16(2):133-6. PubMed ID: 5820142
[No Abstract] [Full Text] [Related]
8. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
Creech HJ; Preston RK; Peck RM; O'Connell AP
J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
[No Abstract] [Full Text] [Related]
9. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
Horváth IP; Institóris L
Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
[No Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of 6-ethynyluracil, a thiol-specific alkylating pyrimidine.
Schroeder AC; Bloch A; Perman JL; Bobek M
J Med Chem; 1982 Oct; 25(10):1255-8. PubMed ID: 7143368
[TBL] [Abstract][Full Text] [Related]
11. Chromosome aberrations induced in human leukocytes by the antitumour multipeptide compound "peptichemio". A light and electronmicroscopic study.
Ruzicka F; Nowotny H
Mikroskopie; 1973 Dec; 29(11):325-30. PubMed ID: 4777005
[No Abstract] [Full Text] [Related]
12. Cytembena treatment of advanced gynaecological carcinomas.
Dvorák O
Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520
[No Abstract] [Full Text] [Related]
13. Anticancer activities of 2,3-dihydro-1,4-benzothiazines, and of their 4-(N-alkyl amides) and 4-(N-alkyl N-nitrosoamides).
Gupta RR; Dev PK; Sharma ML; Rajoria CM; Gupta A; Nyati M
Anticancer Drugs; 1993 Oct; 4(5):589-92. PubMed ID: 8292818
[No Abstract] [Full Text] [Related]
14. Substances with antineoplastic effect. XL. The influence of sodium salt of beta-4-methoxybenzoyl-beta-bromacrylic acid (MBBA) and some related substances on the respiration of rat liver homogenate and Yoshida ascites rat sarcoma cells; the influence of these substances on the mechanisms of oxidative phosphorylation of the liver homogenate.
Helia O; Jindra A; Semonský M
Neoplasma; 1969; 16(6):597-604. PubMed ID: 5369025
[No Abstract] [Full Text] [Related]
15. [Progress in the field of drug development. 6].
Koch H; Mayr E; Richter J; Selchau M
Pharmazie; 1973; 28(11):691-713. PubMed ID: 4151594
[No Abstract] [Full Text] [Related]
16. [Antineoplastic agents. 44. Nuclear substituted beta-benzoyl-beta-brom(chlor)acryl acids and beta-4-methoxybenzoyl-alpha-bromacryl acid].
Semonský M; Zikán V; Vrba L; Jelínek V; Slavíková V; Slavík K; Kakác B
Pharmazie; 1971 May; 26(5):286-91. PubMed ID: 5563060
[No Abstract] [Full Text] [Related]
17. The influence of alkylants, antimetabolites and chloroquine on oxydative biotransformation reactions and on the excretion of ascorbic acid in the rat.
Traeger A; Bauer B; Klinger W; Ankermann H
Acta Biol Med Ger; 1973; 30(3):423-34. PubMed ID: 4800889
[No Abstract] [Full Text] [Related]
18. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
Sugiura K; Merker PC
Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
[No Abstract] [Full Text] [Related]
19. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
Mangione F; Taverna L
Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
[No Abstract] [Full Text] [Related]
20. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
